Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Treatment with TNF inhibitors for uveitis associated with juvenile idiopathic arthritis

Nature Clinical Practice Rheumatology volume 3, pages 608–609 (2007)Cite this article

boxed-textFoeldvari I et al. (2007) Tumor necrosis factor-α blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey. J Rheumatol 34: 1146–1150

Infliximab is an efficacious corticosteroid-sparing agent for patients with JIA uveitis; however, etanercept has not shown similar efficacy, and larger prospective studies will be needed to substantiate this conclusion

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Levy-Clarke GA et al. (2005) Management of chronic pediatric uveitis. Curr Opin Ophthalmol 16: 281–288

    Article  Google Scholar 

  2. Schmeling H and Horneff G (2005) Etanercept and uveitis in patients with juvenile idiopathic arthritis. Rheumatology (Oxford) 44: 1008–1011

    Article  CAS  Google Scholar 

  3. Smith JA et al. (2005) A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. Arthritis Rheum 53: 18–23

    Article  CAS  Google Scholar 

  4. Tynjälä P et al. (2007) Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis. Ann Rheum Dis 66: 548–550

    Article  Google Scholar 

  5. Jabs DA et al. (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140: 509–516

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Jasmine Farsarakis, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. G Levy-Clarke is the Director of the Uveitis and Ocular Immunology Fellowship, S Gangaputra is a Postdoctoral Fellow and R Nussenblatt is the Chief of the Laboratory of Immunology at the National Eye Institute, NIH, Bethesda, MD, USA.,

    Grace Levy-Clarke, Sapna Gangaputra & Robert Nussenblatt

Authors
  1. Grace Levy-Clarke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sapna Gangaputra
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert Nussenblatt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sapna Gangaputra.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Levy-Clarke, G., Gangaputra, S. & Nussenblatt, R. Treatment with TNF inhibitors for uveitis associated with juvenile idiopathic arthritis. Nat Rev Rheumatol 3, 608–609 (2007). https://doi.org/10.1038/ncprheum0630

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0630

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing